Implantable device revolutionizes thyroid management

A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time.

GSK receives Japanese approval for RSV vaccine

The antigen is combined with the AS01E adjuvant of GSK. Credit: GSK. GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW)

September 26, 2023

Final sale: my eight-year struggle to return recalled breast implants

In 2016, I became the owner of a dangerous product that has since been recalled. Considering its significant cost — an average of $4,875, not

January 21, 2025

Statin-Antibiotic Combo Shows No Benefit for Decompensated Cirrhosis

Adding simvastatin and rifaximin to standard therapy for decompensated cirrhosis does not improve clinical outcomes, a double-blind phase III trial showed. For the primary endpoint,

February 6, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.